antifungal therapy – Page 22

Invasive Candidiasis in Contexts of Armed Conflict, High Violence, and Forced Displacement in Latin America and the Caribbean (2005–2025)

mycolabadmin

This comprehensive review examines candida fungal infections in conflict-affected areas of Latin America and the Caribbean, where wars, violence, and displacement create dangerous conditions that make infections more likely and harder to treat. In these regions, mortality from candida bloodstream infections reaches 65% or higher among displaced populations, compared to about 45-60% in regular hospitals. The main problems are lack of proper diagnostic equipment, limited access to effective antifungal medications, malnutrition, overcrowding in shelters, and the emergence of drug-resistant fungal strains.

Cryptococcal endophthalmitis in a patient with malignancy: A case report and literature review

mycolabadmin

A 50-year-old woman with advanced lung cancer developed a rare fungal eye infection caused by Cryptococcus neoformans, resulting in blurred vision. Doctors diagnosed this through eye surgery and fluid analysis, then treated her with strong antifungal medications both injected into the eye and given systemically. After 10 months of treatment, her vision significantly improved, showing that early detection and aggressive antifungal therapy are critical for preventing blindness from this rare infection.

In vitro activity of SF001: a next-generation polyene versus amphotericin B

mycolabadmin

This study tested a new antifungal drug called SF001 against a well-established antifungal called amphotericin B. Researchers tested both drugs against common fungal infections affecting vulnerable patients. SF001 was found to work as well as or better than amphotericin B, particularly against harder-to-treat Aspergillus fungi, while potentially causing fewer side effects.

Mycobiome of Stool, Blood, Thrombus and Vessel Wall in Abdominal Aortic Aneurysm Patients

mycolabadmin

This study examined fungal communities in blood, stool, and damaged aorta tissues from patients with abdominal aortic aneurysm, a serious condition where the main blood vessel weakens and bulges. Researchers found that healthy blood vessels contain protective fungi called Tomentella, while damaged vessels have high levels of harmful fungi called Malassezia. Interestingly, the fungi found in damaged vessel walls may not come directly from the gut, suggesting they originate from other body parts like the mouth or skin. These findings suggest that controlling fungal communities with targeted antifungal treatments might help prevent or slow aneurysm development.

Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report

mycolabadmin

A 74-year-old man with leukemia developed a serious fungal infection (mucormycosis) on his ankle while taking cancer-fighting drugs. The infection was diagnosed through tissue biopsy examination rather than standard culture tests. Treatment required both powerful antifungal medications and surgical removal of the infected leg below the knee. The patient recovered successfully after this aggressive treatment approach.

The antifungal mechanism of EntV-derived peptides is associated with a reduction in extracellular vesicle release

mycolabadmin

Researchers discovered that a small peptide derived from a bacterium called EntV can fight Candida fungal infections by targeting specialized vesicles (tiny sacs) that fungi use to spread infections. Unlike traditional antifungal drugs that kill fungi, EntV works by blocking the release of these vesicles, reducing the fungus’s ability to infect and form protective biofilms. This new approach could lead to treatments that work against drug-resistant fungi without the toxicity issues of current antifungals.

Cryptococcus albidus (Naganishia albida) meningitis in a young patient with T-cell acute lymphoblastic leukaemia

mycolabadmin

A 16-year-old boy with blood cancer developed meningitis caused by a rare fungus called Cryptococcus albidus. Doctors initially thought he had a viral infection, but laboratory tests identified the fungus. He was treated with antifungal medications and improved significantly. This case shows how important it is to identify the correct cause of infection quickly, especially in patients with weakened immune systems.

The role of Npt1 in regulating antifungal protein activity in filamentous fungi

mycolabadmin

Researchers discovered how antifungal proteins work against a dangerous fungus (Aspergillus flavus) that damages crops and produces toxins. They found that these proteins break down the fungal cell wall and then interact with an internal fungal protein called Ntp1. By understanding exactly which part of Ntp1 the antifungal proteins bind to, scientists can now develop better treatments to protect food crops from fungal diseases.

The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum

mycolabadmin

Researchers discovered that a protein called TrPtk2 helps dermatophytes resist terbinafine, a common antifungal medicine. They found that blocking this protein makes the fungus more susceptible to terbinafine. Additionally, they discovered that omeprazole, a stomach medication approved for human use, can be combined with terbinafine to make it more effective against resistant fungal infections.

When Emerging Fungal Infections Mimic Tuberculosis: First Reported Case of Invasive Emergomyces europaeus Infection in a Man With Immunocompromise Living in France

mycolabadmin

A 65-year-old man living in France who received a kidney transplant developed a serious fungal infection caused by Emergomyces europaeus, a rare fungus that initially appeared to be tuberculosis. Doctors used advanced genetic testing to identify the unusual fungus in samples from his lungs and bone marrow. The patient was treated with a combination of antifungal medications, which successfully cleared the infection. This is the first time this particular fungal infection has been documented in France and highlights how emerging infections can mimic more common diseases.

Research Keyword: antifungal therapy